PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 03/13/2013 -- Velti plc (Nasdaq: VELT) reported Q4 EPS of $0.39, $0.20 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $97.5 million versus the consensus estimate of $106 million.The Company was guiding revs of $97.1 million to $113.1 million and adjusted EBITDA of $50.8 million to $59.8 million. (Adjusted EBITDA for Q412 came in at $25.14 million, shy of internal expectations.)
Sees FY2013 revenue of $255-$280 million, versus the consensus of $339.5 million. Expects adjusted EBITDA of $5 million to $15 million.Also sees Q1 2013 revenue of $40-$44 million, versus the consensus of $62.7 million. Sees adjusted EBITDA as a loss of $17 million to $15 million.
For earnings history and earnings-related data on Velti plc (VELT) click here.
BG Medicine, Inc. (NASDAQ:BGMD) a life sciences company that engages in the discovery, development, and commercialization of novel cardiovascular diagnostics to address unmet medical needs is currently up (+13.33%) on 1,511,913 shares traded after BG Medicine Reported Fourth Quarter and Full Year 2012 Financial Results and Provided 2013 Outlook. BG Medicine, Inc. (NASDAQ:BGMD) is currently up (+124%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about BG Medicine, Inc. (NASDAQ:BGMD)
MEMC Electronic Materials Inc. (NYSE:WFR) said it is filing a Form 8-K today with the Securities and Exchange Commission to provide the slides that will be presented later today at the company's Capital Markets Day in Belmont, California, as well as a 2013 financial outlook and details on a forthcoming company name change proposal to shareholders.
Looking ahead, the company expects Capex between $30 million and $40 million for the first quarter of 2013, and between $120 million and $140 million for the full year 2013.MEMC would be holding a capital markets day today, March 13, 2013. Additionally, the company announced its plan to change its name to SunEdison, Inc.
Click here to receive FREE breaking news email alerts for MEMC Electronic Materials Inc.
MELA Sciences, In (NCM:MELA) is -0.05 - -4.20% from the previous close of $1.19. It traded between $1.08 - 1.20 with total traded volume of 1144951 shares. Keep a close eye on MELA, as the stock has been showing unusual moves over the past weeks. At Current market price, MELA has recovered -2.56% from its 52-week Low of 1.17 and has Pulled back -76.59% from its 52-week high of 4.87.
How Should Investors Trade MELA Now? Find Out Here
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)